Do they deserve BTD for symptom relief? Have they proven it with sufficient science? Today pharma's if they look hard enough in a trial they can find something g to hang their hat on, but should the FDA award BTD when the actual trial's two primary outcomes, isn't what the BTD will be about. I believe the two lag in ph3 is the strongest red flag that this drug faces.
The talk today is the shorts have stymied the share price. Really, it has nothing to do with any doubts. The stock was .50 and now $1.82 and some feel that it should be higher? What exactly have you produced as a reward for a higher valuation? If they had fired up the ph3 they would be half way through it by now and maybe giving some mid term data. But instead they taking a short cut and investors are all giddy.
What bums you out isn't the shorts, it's that you cannot sell the sizzle any more. That the insider buys didn't carry any weight. I hope that you do get what you seek, but I just cannot see where a company should be rewarded for not follow through on what they told investors. This is a hail mary and sometimes it works, but from the cheap seats, all I see is them calling a audible.
Why didn't the company in any PR early, state the symptom approach was their angle. When pressed by AF, they finally came clean. Why didn't they secretly apply for BTD and just surprise investors? Go back and read the original notice to investors about BTD. Then compare it to the new facts. Here's what I believe happen. The company came to the realization the drug needed help. That a PH1 would have to be opened in combination. If they admit to shareholders they needed to start over, the stock plummets. So what could they do? I think you know the rest of the story. Little bit of smoke and mirrors, some dilution that they can sell to the retail on Ph2 combination. Sorry Charlie the FDA just didn't see our way. They leave the retail with some small hope down the road. Rose Bengal glasses.
Feels more like a slinky going down the steps. Long so don't shoot the messenger. Called them yesterday, no return call. Their IR department sucks. I have this at an average cost of $4.90. Sold some shares at $8.90 range wish I had dump a few more. I'm not happy that they want to pay Swartz $200K a year. But maybe there's a plan.
Spandex tries so hard. The street rewards what you are doing 6 months from now. When earnings come out that's old news. Todays buying is based on June's numbers. It seems that spandex is always thinking backwards. He doesn't understand tax credits and the ability for the company to turn a nice profit and offset any tax consequence with these credits. You get to keep more of what you made. It masks nothing spandex. Pre-expenses? Take an accounting class...spandex. You like to use the word GAAP, but have little understanding what it means.
I have to double check to see if they are guiding for a $40M Operating profit in Oil and gas or they are saying that it will be $40M better than last year. The difference is they lost $40M in operating profits last year in the first three quarters and so basically they could be saying breakeven this year in oil and gas?
They discussed the weather in detail and stated they feel the impact would be manageable. You screwed up bragging you sold at $8.35 range. You can only blame yourself spandex. Near term events is landing the third MSA and maybe another one in Utility. These are $100M contracts with good margins.
Because their in the money and maybe soon not? That's my best guess. Most CEO's would hold off till after they get positive development. It seems your group likes to be at the front of the line.
I'm sure a alpha article will soon appear helping this get hyped.
The only rough part of the news was they didn't hang onto more of the profits. The street would like to see some of the $15.5M. Interest and taxes eat most of it. Canada gets 25% of the profits we see back in taxes. They have guided that each quarter will look better. Two more MSA agreements should seal the deal that we hit above the higher ranges. $300M improve this year guarantee's a solid profit this year. Company has stated at least a $40M turn around in Oil and Gas. The tax credits will off set any tax liability in the States.
Volume has picked up. Let's get this party started. The more I research the science the stronger feeling I get that this could be huge down the road.
Must have been when you released your lips from Zeev hind end. Maybe BZNE will develop a cold sore remedy that you can take once a day. Company stated there was a endless amount of viruses they can go after. Send them some DNA from your lip sores and see what they can do.
Spandex is a winner after the facts always. He stated he sold 5000 shares at $8.25 range and that we were headed to the $7's. He should be thanking me that he has any shares to sell in the high $9's. Why invest in a stock you have zero clue about.
Just as long as everyone sees what we see. That's all that matters.
Meant in the past few days they exercised. Why not wait for the FDA decision? Unless they expected not to see a $1.10 in the future.
It's easy to judge that the pumpers would run with this story. Why would they exercise today. Were these options expiring? Everyone associated with this stocks knows exactly what the pumpers would do here. Just like clock work, they begin seeing this as positive. It could be insiders know that BTD will not be granted, so they better take advantage of the situation. Two sides to every coin.
They received the settlement in the first quarter. Why does spandex and gulf boom both suffer from the same infliction? Both spandex and boom look backwards....hmmm. Gulf boom was the same id that stated they don't recover in lawsuits. How these guys dress themselves is anyone's guess.
What prior management did these guys are cleaning up. Spandex bragged about selling 80K shares and today missed $99K of valuation. Now all we need is crammer to highlight the turn around and maybe we can double that loss for spandex.
Do they keep them? Their up .74 on 600K that some tempting cheese. So not only did you pay them $3M a year, you awarded them some very cheap options.
If they sell them, start working on the excuses. That's what retail pumpers do best here.
Did you put eraser boy and his 5 aliases on ignore? How about the team of nitwits pumping the ph1 trial in liver that is 5 years old, starting over? So many of them to ignore and so little time cathy.